Ligand ID: 41X Drugbank ID: DB00234(Reboxetine) Indication:For the treatment of clinical depression. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 5r84 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.47A | 20.29 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.50A | 14.93 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.47A | 20.37 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.52A | 20.37 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 11 | ASP C 176TYR C 161GLY C 29VAL C 86GLY C 179 | 1.54A | 20.29 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 11 | ASP B 176TYR B 161GLY B 29VAL B 86GLY B 179 | 1.59A | 20.29 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.61A | 20.29 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 11 | ASP D 176TYR D 161GLY D 29VAL D 86GLY D 179 | 1.59A | 20.29 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.48A | 20.29 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 11 | PHE A 48ALA A 125ASP A 126TYR A 129GLY A 44 | 1.56A | 20.48 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 11 | ASP A 717ALA A 706VAL A 776TYR A 770GLY A 774 | 1.68A | 20.48 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 11 | ASP A 717ALA A 706TYR A 770GLY A 712GLY A 774 | 1.63A | 20.48 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6m71 | NSP12 (SARS-CoV-2) | 6 / 11 | ASP A 623VAL A 667TYR A 453TYR A 456GLY A 683VAL A 662 | 1.79A | 20.48 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | ALA C 890VAL B1040ASP B1041GLY B 910GLY B1046 | 1.54A | 18.68 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 5 / 11 | PHE C 515ALA C 397VAL C 511GLY C 431VAL C 395 | 1.73A | 15.77 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | ASP A6895GLY A6879VAL B4295SER A6903GLY B4322 | 1.61A | NoneSAM A7104 (-3.6A)NoneNoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.49A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | ASP C6895GLY C6879VAL D4295SER C6903GLY D4322 | 1.58A | 15.56 | NoneSAM C7105 ( 3.4A)NoneNoneNone | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | ASP C6895TYR C6845GLY C6875SER C6903GLY D4322 | 1.80A | 15.56 | NoneSAM C7105 ( 4.5A)NoneNoneNone | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | ASP A6895GLY A6879VAL B4295SER A6903GLY B4322 | 1.58A | 15.56 | NoneSAM A7102 ( 3.4A)NoneNoneNone | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 11 | ASP B 302ALA B 114TYR B 112TYR B 273SER B 262 | 1.67A | None CL B 502 ( 3.8A)NoneNoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 11 | ASP A 302ALA A 114TYR A 112TYR A 273SER A 262 | 1.78A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 11 | ASP C 302ALA C 114TYR C 112TYR C 273SER C 262 | 1.73A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 11 | ALA C 141TYR C 136GLY C 100SER C 103GLY C 142 | 1.44A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | ASP A6895GLY A6879VAL B4295SER A6903GLY B4322 | 1.59A | NoneSAH A7102 (-3.5A)NoneNoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | ASP C6895GLY C6879VAL D4295SER C6903GLY D4322 | 1.58A | NoneSAH C7102 (-3.5A)NoneNoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | ASP C6895TYR C6845GLY C6875SER C6903GLY D4322 | 1.80A | NoneSAH C7102 (-4.6A)NoneNoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | ASP A6895TYR A6845GLY A6875SER A6903GLY B4322 | 1.79A | NoneSAH A7102 (-4.6A)NoneNoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | ASP A6895TYR A6845GLY A6875SER A6903GLY B4322 | 1.78A | NoneSFG A7103 ( 4.6A)NoneNoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | ASP C6895TYR C6845GLY C6875SER C6903GLY D4322 | 1.79A | NoneSFG C7103 ( 4.5A)NoneNoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | ASP C6895GLY C6879VAL D4295SER C6903GLY D4322 | 1.58A | NoneSFG C7103 ( 3.5A)NoneNoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | ASP A6895GLY A6879VAL B4295SER A6903GLY B4322 | 1.57A | NoneSFG A7103 ( 3.5A)NoneNoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.48A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | ASP A6895GLY A6879VAL B4295SER A6903GLY B4322 | 1.59A | NoneSAH A7101 (-3.5A)NoneNoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | ASP A6895TYR A6845GLY A6875SER A6903GLY B4322 | 1.79A | NoneSAH A7101 (-4.5A)NoneNoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.56A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 11 | ALA A 141TYR A 136GLY A 100SER A 103GLY A 142 | 1.37A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.50A | 14.93 | None | ||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | PHE A 515VAL A 433VAL A 382SER A 514GLY A 431 | 1.70A | NoneNoneDMS A 905 (-4.3A)NoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | PHE E 515ALA E 397VAL E 511GLY E 431VAL E 395 | 1.78A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | PHE A 515ALA A 397VAL A 511GLY A 431VAL A 395 | 1.77A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | PHE E 515VAL E 433VAL E 382SER E 514GLY E 431 | 1.70A | NoneNoneDMS L1601 (-4.2A)NoneNone | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | PHE E 515VAL E 433VAL E 382SER E 514GLY E 431 | 1.71A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | PHE E 515ALA E 397VAL E 511GLY E 431VAL E 395 | 1.77A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.49A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | PHE E 515ALA E 397VAL E 511GLY E 431VAL E 395 | 1.77A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | PHE A 515ALA A 397VAL A 511GLY A 431VAL A 395 | 1.78A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | PHE E 515VAL E 433VAL E 382SER E 514GLY E 431 | 1.70A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | PHE A 515VAL A 433VAL A 382SER A 514GLY A 431 | 1.69A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.51A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.50A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7btf | NSP12 (SARS-CoV-2) | 5 / 11 | ASP A 623TYR A 453TYR A 456GLY A 683VAL A 662 | 1.73A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7btf | NSP12 (SARS-CoV-2) | 5 / 11 | ASP A 717ALA A 706VAL A 776TYR A 770GLY A 774 | 1.64A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7btf | NSP12 (SARS-CoV-2) | 5 / 11 | PHE A 48ALA A 125ASP A 126TYR A 129GLY A 44 | 1.58A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7btf | NSP12NSP7 (SARS-CoV-2) | 5 / 11 | ASP A 845ALA A 443VAL A 410TYR A 546VAL C 11 | 1.53A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7btf | NSP12 (SARS-CoV-2) | 5 / 11 | ALA A 580GLY A 584VAL A 588SER A 592GLY A 590 | 1.56A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 11 | ASP A 176TYR A 161GLY A 29VAL A 86GLY A 179 | 1.52A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 11 | ASP A 717ALA A 706VAL A 776TYR A 770GLY A 774 | 1.58A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 11 | ASP A 623TYR A 453TYR A 456GLY A 683VAL A 662 | 1.72A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 11 | PHE A 48ALA A 125ASP A 126TYR A 129GLY A 44 | 1.57A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7bv2 | NSP12 (SARS-CoV-2) | 6 / 11 | ASP A 623VAL A 667TYR A 453TYR A 456GLY A 683VAL A 662 | 1.79A | POP A1003 ( 3.5A)NoneNoneNone U T 10 ( 3.1A)None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 11 | ASP A 717ALA A 706VAL A 776TYR A 770GLY A 774 | 1.69A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 11 | PHE A 48ALA A 125ASP A 126TYR A 129GLY A 44 | 1.63A | None | |||
![]() | 4XNX_A_41XA707_1 (TRANSPORTER) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 11 | ALA A 125VAL A 128ASP A 126TYR A 129GLY A 44 | 1.60A | None |